The pharmacist confirms suitability, stock and the required dose schedule before treatment
BPC-157 is a synthetic 15-amino-acid peptide fragment originally isolated from human gastric juice, where it occurs as part of a larger body-protective protein
The supplement is particularly popular among high school, college, and professional athletes, especially football and hockey players, wrestlers, and gymnasts
These changes are reflected in Table 76
Intern Med 1999;38(6):472-75 9
The conditions that most commonly support eligibility include: Obesity (BMI 30, or 27 with at least one comorbidity such as hypertension, sleep apnea, or cardiovascular disease) Type 2 diabetes or prediabetes Insulin resistance with clinical documentation Metabolic syndrome (clinically diagnosed) Polycystic Metabolic Ovarian Syndrome (PMOS) and related hormonal disorders Non-alcoholic fatty liver disease (NAFLD/MASLD) Perimenopause-related metabolic dysfunction with documented hormonal changes GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide are the most commonly used peptides in metabolic care today